Published in J Invest Dermatol on May 01, 1992
GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest (2005) 1.88
beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. J Clin Invest (2009) 1.79
Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans. Proc Natl Acad Sci U S A (2006) 1.44
The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903]. BMC Clin Pharmacol (2003) 1.05
Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia. Br J Pharmacol (2009) 0.99
Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid. J Clin Invest (2005) 0.96
How much do we really know about our favorite cosmeceutical ingredients? J Clin Aesthet Dermatol (2010) 0.93
The mechanism and mitigation of niacin-induced flushing. Int J Clin Pract (2009) 0.92
Familial aggregation in skin flush response to niacin patch among schizophrenic patients and their nonpsychotic relatives. Schizophr Bull (2006) 0.89
Aldo-keto reductase 1C3 is expressed in differentiated human epidermis, affects keratinocyte differentiation, and is upregulated in atopic dermatitis. J Invest Dermatol (2011) 0.88
Niacin and biosynthesis of PGD₂by platelet COX-1 in mice and humans. J Clin Invest (2012) 0.88
Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia. Vasc Health Risk Manag (2009) 0.87
Impaired flush response to niacin skin patch among schizophrenia patients and their nonpsychotic relatives: the effect of genetic loading. Schizophr Bull (2008) 0.87
HDL abnormalities in nephrotic syndrome and chronic kidney disease. Nat Rev Nephrol (2015) 0.82
Niacin sensitivity and the arachidonic acid pathway in schizophrenia. Schizophr Res (2010) 0.81
Niacin, an old drug with a new twist. J Lipid Res (2013) 0.81
The treatment of migraines and tension-type headaches with intravenous and oral niacin (nicotinic acid): systematic review of the literature. Nutr J (2005) 0.79
A genome-wide quantitative linkage scan of niacin skin flush response in families with schizophrenia. Schizophr Bull (2011) 0.79
Niacin inhibits skin dendritic cell mobilization in a GPR109A independent manner but has no impact on monocyte trafficking in atherosclerosis. Immunobiology (2011) 0.79
The flavonoid luteolin inhibits niacin-induced flush. Br J Pharmacol (2008) 0.77
High dietary niacin may increase prostaglandin formation but does not increase tumor formation in ApcMin/+ mice. Nutr Cancer (2011) 0.77
Targeting multiple dyslipidemias with fixed combinations--focus on extended release niacin and simvastatin. Vasc Health Risk Manag (2008) 0.77
Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosis. J Lipid Res (2012) 0.77
Effect of niacin on the choroidal circulation of patients with age related macular degeneration. Br J Ophthalmol (2004) 0.76
Effects of pyrazole partial agonists on HCA(2) -mediated flushing and VLDL-triglyceride levels in mice. Br J Pharmacol (2012) 0.76
Extended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parameters. Clin Med Insights Cardiol (2011) 0.75
Stability of methylnicotinate in aqueous solution as utilized in the 'niacin patch test'. BMC Res Notes (2008) 0.75
Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther (1970) 9.54
A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A (1990) 5.31
Disability income, cocaine use, and repeated hospitalization among schizophrenic cocaine abusers--a government-sponsored revolving door? N Engl J Med (1995) 4.77
Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med (1995) 3.91
Evidence that histamine is the causative toxin of scombroid-fish poisoning. N Engl J Med (1991) 3.65
Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice. J Biol Chem (1997) 3.42
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med (2005) 3.13
Urinary prostaglandins. Identification and origin. J Clin Invest (1975) 3.07
Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal Biochem (1990) 2.84
Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol (1982) 2.69
The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents. N Engl J Med (1965) 2.64
Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med (1975) 2.63
Methods for defining and determining the clinical significance of treatment effects: description, application, and alternatives. J Consult Clin Psychol (1999) 2.60
Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci U S A (1992) 2.51
Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med (1978) 2.50
Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol (1999) 2.40
Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science (1976) 2.39
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. JAMA (1999) 2.34
Clinical experience over 48 years with pheochromocytoma. Ann Surg (1999) 2.32
Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man. J Clin Invest (1970) 2.29
Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat Med (1999) 2.26
Estimated rate of prostacyclin secretion into the circulation of normal man. J Clin Invest (1981) 2.18
Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology (1999) 2.16
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest (1983) 2.13
Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med (1986) 2.03
Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest (1981) 2.03
The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res (1997) 2.02
Measurement of lipid peroxidation. Free Radic Res (1998) 1.91
Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. J Clin Invest (1994) 1.89
Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation (1979) 1.88
Ionophores stimulate prostaglandin and thromboxane biosynthesis. Proc Natl Acad Sci U S A (1977) 1.82
Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. J Clin Invest (1992) 1.77
Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J Biol Chem (1994) 1.76
Pharmacologic and endocrine aspects of carcinoid syndrome. Adv Pharmacol (1967) 1.74
Antagonism of the antihypertensive action of guanethidine sulfate by desipramine hydrochloride. JAMA (1967) 1.67
Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med (1980) 1.63
Suppression of plasma renin activity by indomethacin in man. Circ Res (1976) 1.62
Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha). Clin Exp Allergy (2001) 1.62
Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids. Immunology (1980) 1.60
Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc Natl Acad Sci U S A (1999) 1.57
Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype. Br J Clin Pharmacol (1978) 1.57
Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans. Proc Natl Acad Sci U S A (1985) 1.55
Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am J Med (1976) 1.55
Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med (1994) 1.54
The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol (1996) 1.53
Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. Prostaglandins (1989) 1.49
Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts. J Biol Chem (1999) 1.47
Are anaesthetists prone to suicide? A review of rates and risk factors. Anaesth Intensive Care (2003) 1.46
Clinical implications of prostaglandin and thromboxane A2 formation (1). N Engl J Med (1988) 1.45
Prevention of skin cancer in xeroderma pigmentosum: the physician as advocate. J Am Acad Dermatol (1993) 1.44
Chlorpromazine reversal of the antihypertensive action of guanethidine. Lancet (1971) 1.43
Hypertension and fibromuscular dysplasia of the renal arteries. Surgery (1969) 1.42
Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med (2005) 1.42
The effects of alcohol on the marital interactions of aggressive and nonaggressive husbands and their wives. J Abnorm Psychol (1998) 1.41
Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer. J Biol Chem (1985) 1.40
Inhibition of monoamine oxidase in man by furazolidone. Clin Pharmacol Ther (1968) 1.40
Urticaria pigmentosa. Systemic evaluation and successful treatment with topical steroids. Arch Dermatol (1991) 1.40
(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2. Nat Chem Biol (2011) 1.39
Nashville experience with liver transplantation in Veterans Administration patients. J Surg Res (1997) 1.39
Idiopathic thrombocytopenic purpura in pregnancy: a randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol (1991) 1.39
Prostaglandin thromboxane, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells. Biochim Biophys Acta (1979) 1.39
Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem (1997) 1.38
A physiologic concept of exercise-induced pulmonary hemorrhage in horses. J Am Vet Med Assoc (1992) 1.38
Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc Natl Acad Sci U S A (1990) 1.38
Placental isoprostane is significantly increased in preeclampsia. FASEB J (2000) 1.38
Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med (1978) 1.37
Biosynthesis of prostaglandin D2. 1. Formation of prostaglandin D2 by human platelets. Prostaglandins (1977) 1.36
Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites. J Biol Chem (1981) 1.35
Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay. Anal Biochem (1999) 1.34
Leishmaniasis host response loci (lmr1-3) modify disease severity through a Th1/Th2-independent pathway. Genes Immun (2004) 1.33
Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man. Clin Pharmacol Ther (1978) 1.33
Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism. Methods Enzymol (1994) 1.33
Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Cancer Chemother Pharmacol (2013) 1.33
A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem (1998) 1.33
Blockade of the flush associated with metastatic gastric carcinoid by combined histamine H1 and H2 receptor antagonists. Evidence for an important role of H2 receptors in human vasculature. N Engl J Med (1979) 1.32
The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins (1992) 1.30
Arachidonic acid 15-lipoxygenase products from human eosinophils. J Biol Chem (1982) 1.30
Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide. Am J Cardiol (1981) 1.28
Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation (1987) 1.27
Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway. J Biol Chem (1999) 1.27
Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. Am J Pathol (2001) 1.26
Guanethidine and related agents. I. Mechanism of the selective blockade of adrenergic neurons and its antagonism by drugs. J Pharmacol Exp Ther (1970) 1.26
Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J Clin Invest (1992) 1.26
Oxygenation of arachidonic acid by hepatic monooxygenases. Isolation and metabolism of four epoxide intermediates. J Biol Chem (1982) 1.26
Effect of indomethacin and aspirin on gastric blood flow and acid secretion. J Pharmacol Exp Ther (1977) 1.25